Nanoviricides Inc (NNVC)
1.34
+0.06
(+4.69%)
USD |
NYAM |
Nov 22, 16:00
1.34
0.00 (0.00%)
After-Hours: 20:00
Nanoviricides Cash from Financing (Quarterly): 1.710M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.710M |
| June 30, 2024 | 3.12M |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -0.0238M |
| September 30, 2022 | -0.071M |
| June 30, 2022 | -0.0327M |
| March 31, 2022 | -0.0693M |
| December 31, 2021 | -0.0614M |
| September 30, 2021 | -0.0713M |
| June 30, 2021 | -0.0705M |
| March 31, 2021 | 6.052M |
| December 31, 2020 | -1.075M |
| September 30, 2020 | 10.35M |
| June 30, 2020 | 9.316M |
| March 31, 2020 | 7.795M |
| December 31, 2019 | 0.9589M |
| September 30, 2019 | -0.2421M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 2.35M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | -1.00M |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.061M |
| September 30, 2014 | 6.682M |
| June 30, 2014 | 5.00M |
| March 31, 2014 | 19.44M |
| December 31, 2013 | 0.025M |
| September 30, 2013 | 9.876M |
| June 30, 2013 | -0.0975M |
| March 31, 2013 | 4.286M |
| December 31, 2012 | 2.322M |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 2.187M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.075M
Minimum
Dec 2020
10.35M
Maximum
Sep 2020
1.892M
Average
--
Median
Mar 2023
Cash from Financing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 2.089M |
| Palatin Technologies Inc | -0.127M |
| iBio Inc | -0.162M |
| Theriva Biologics Inc | 3.716M |
| Oragenics Inc | 3.766M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.595M |
| Cash from Investing (Quarterly) | -0.0468M |
| Free Cash Flow | -7.934M |
| Free Cash Flow Per Share (Quarterly) | -0.1926 |
| Free Cash Flow Yield | -47.86% |